Skip to main content
Equibles
MCRB logo

MCRB · Seres Therapeutics, Inc. · Debt

Track MCRB — free

Use MCRB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MCRB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.35 -0.13 (-3.74%) At close · Sep 30
Rebalance outlook locked
Going-concern doubt — flagged Aug 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 5, 2026
Market Cap
$34.99M
Shares
9.94M
Volume · Sep 30 54.61K Avg daily vol (3M) 73.92K

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1609809 CUSIP 81750R201 13F (30d) 2 filings 2 filers Visit website Investor relations